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Abstract
Temperate bacteriophages express transcription repressors that maintain lysogeny by
down-regulating lytic promoters and confer superinfection immunity. Repressor regulation
is critical to the outcome of infection—lysogenic or lytic growth—as well as prophage induc-
tion into lytic replication. Mycobacteriophage BPs and its relatives use an unusual integra-
tion-dependent immunity system in which the phage attachment site (attP) is located within
the repressor gene (33) such that site-specific integration leads to synthesis of a prophage-
encoded product (gp33103) that is 33 residues shorter at its C-terminus than the virally-
encoded protein (gp33136). However, the shorter form of the repressor (gp33103) is stable
and active in repression of the early lytic promoter PR, whereas the longer virally-encoded
form (gp33136) is inactive due to targeted degradation via a C-terminal ssrA-like tag. We
show here that both forms of the repressor bind similarly to the 33–34 intergenic regulatory
region, and that BPs gp33103 is a tetramer in solution. The BPs gp33103 repressor binds to
five regulatory regions spanning the BPs genome, and regulates four promoters including
the early lytic promoter, PR. BPs gp33
103 has a complex pattern of DNA recognition in which
a full operator binding site contains two half sites separated by a variable spacer, and BPs
gp33103 induces a DNA bend at the full operator site but not a half site. The operator site
structure is unusual in that one half site corresponds to a 12 bp palindrome identified previ-
ously, but the other half site is a highly variable variant of the palindrome.
Introduction
Following adsorption and DNA injection, temperate phages must choose between two alterna-
tive outcomes: lytic growth in which the phage replicates and the cell lyses to release progeny
phage particles, or lysogeny in which the lytic genes are switched off and a prophage genome is
maintained either by site-specific chromosomal integration, or stable extrachromosomal repli-
cation [1]. In the well-studied example of phage lambda, lysogenic maintenance is achieved by
expression of a repressor (cI) that binds to tripartite operators (OL and OR) at the early lytic
promoters PL and PR [1]. Lambda cI autoregulates its synthesis by activation of its own tran-
scription from the promoter for lysogenic maintenance (PRM) at moderate cI concentrations,
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and represses it when the cI concentration is high. During infection, establishment of lambda
lysogeny occurs by expression of cI from the promoter for lysogenic establishment (PRE),
which is independent of cI, but requires the activator, cII [2]. The decision as to the outcome of
infection is determined by the overall level of cII, which is subject to degradation by host prote-
ases including FtsH, and is modulated by lambda cIII protein [3]. Lambda cI binds as a dimer
and can form DNA loops when bound at both OL and OR [4].
The temperate life style is common among bacteriophages, although the genetic diversity
of the phage population is considerable [5]. Repressors have been identified in many phage
genomes, although relatively few have been genetically and biochemically characterized [5].
The organization of two divergently transcribed DNA-binding proteins—typified by the cI and
cro genes in lambda—separated by a control region is common but not universal. For example,
the repressor of Streptomyces phage ϕC31 is located downstream of the virion structural genes
and is similarly transcribed rightwards [6, 7], and in mycobacteriophage L5 (and its relatives)
the repressor is located within the right arm of the genome and transcribed leftwards along
with other right arm genes [8, 9]. These two systems are also unusual in that the phage
genomes contain multiple (18–30) repressor binding sites dispersed across the genomes, and
the ϕC31 system is further complicated by the expression of three isoforms of the repressor
[10]. The L5 repressor binds as a monomer at the asymmetric non-operator binding sites
(referred to as ‘stoperators’) to block transcription elongation [11]. There are few examples
other than phage lambda and its relatives where the molecular basis of the decision between
lytic and lysogenic outcomes is well understood [12, 13].
Comparative genomic analysis of a large number of completely sequenced mycobacterio-
phages shows them to be highly diverse, and they can be grouped into ‘clusters’ according to
their nucleotide and gene content relationships [14, 15]. A substantial portion of these phages
(~40%), including L5, are grouped in Cluster A, and share the unusual stoperator system of
immunity [11, 16]. The repressor genes have been identified in phages of Clusters G, I, N, and
P [12, 13], Cluster K [17], and the singleton Giles [18], but in each case they are components of
pairs of divergently transcribed genes separated by a putative control region.
Mycobacteriophage BPs and its relatives in Cluster G—along with members of Clusters I,
N, and P—use an unusual integration-dependent immunity system for the establishment and
maintenance of lysogeny [13]. In these systems the repressor and integrase genes (BPs 32 and
33 respectively) are transcribed leftwards, but the phage attachment site (attP) is oddly located
within the repressor open reading frame (see Fig 1A). As a consequence, chromosomal integra-
tion in lysogenic establishment results in separation of the 3’ end of the repressor gene and
expression of a truncated version of the repressor. However, it is this short form of the repres-
sor (e.g. BPs gp33103) that is active in conferring immunity, whereas the virally-encoded longer
form (e.g. BPs gp33136) is not. Inactivation of the virally-encoded form expressed during lytic
growth occurs as a result of proteolytic degradation targeted at an ssrA-like tag at the extreme
C-terminus [13]. Proteolysis of the virally-encoded form is a direct determinant of lysogeniza-
tion frequency, as a mutant expressing a stabilized form of BPs gp33136 establishes lysogeny at
a considerably higher frequency than wild-type BPs. However, lysogenization frequency is also
determined by the frequency of integration, and the integrase protein also contains a C-termi-
nal signal for proteolysis [13].
The BPs 33–34 intergenic region contains two divergent promoters, PR and Prep, responsible
for early lytic expression and repressor synthesis respectively [13, 19] (Fig 1B). The gp33103
active form of the repressor was shown previously to bind to a DNA substrate that includes a
12 bp palindromic sequence, which was presumed to be the operator (OR) regulating transcrip-
tion from the early lytic promoter, PR [13]. This was supported by the mapping of two point
mutations within this 12 bp sequence (5’-CGACATATGTCG) that give rise to a repressor-
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insensitive phage phenotype (i.e. they can form plaques on a repressor-expressing strain) [13].
However, the requirements for DNA binding at OR and at related sequences elsewhere in the
phage genome and the nature of the protein-DNA interactions are not understood. Here we
show that the two forms of the repressor bind similarly to DNA, that the short active form
of the repressor is a tetramer in solution, and that the previously reported 12 bp operator
sequence represents one half of a full binding site.
Results
gp33136 and gp33103 bind similarly to BPs 33–34 intergenic DNA
Electrophoretic mobility shift assays (EMSA) show that gp33103 binds to DNA substrates
containing the 33–34 intergenic control region to form several distinct complexes as protein
Fig 1. The BPs Immunity Cassette. (A) Phage BPs has three genes involved in the lytic/lysogenic growth decision; gene 32 encodes an integrase (gp32),
gene 33 encodes the repressor (gp33), and gene 34 encodes a putative Cro-like protein (gp34). BPs gp33 and gp32 are expressed leftwards from the Prep
promoter and gp34 is expressed rightward from the PR promoter. The attP site for BPs integration is within the 33 open reading frame, such that the prophage
repressor gene is truncated the gene by 99bp. The virally-encoded repressor is 136 residues long (gp33136) and has a C-terminal tag for proteolytic
degradation [13]. This prophage form of the repressor (gp33103) is 33 residues shorter, is stably expressed, and is required to maintain lysogeny. (B) The 33–
34 intergenic region contains two divergent promoters, Prep and PR. The full intergenic region sequence is shown (left part above, right part below) and
promoter -10 and -35 elements are in green. The operator (OR; highlighted in yellow) to which gp33
103 binds to regulate PR is located between the -10 and
-35 elements of PR (green). A second operator, ORep, is located proximal to 33 (highlighted in yellow) downstream of the Prep promoter (green). (C) DNA
included in substrates used for binding assays are shown as horizontal lines above or below the 33–34 intergenic sequence (Mt series and TIR series of
substrates). Regions of DNase I protection are indicated by black lines between the top and bottom strand bases.
doi:10.1371/journal.pone.0137187.g001
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concentration increases (Fig 2A). The combined affinity for gp33103 binding is relatively weak
(2.6 μM; Table 1) and the prominent complex (C4) forms at protein concentrations of 16 μM
and above (Fig 2A); three faster migrating complexes are observed at lower protein concentra-
tions and are likely binding intermediates (Fig 2A). Although DNA binding is relatively weak
compared to other repressors, it is specific as little or no binding is observed with a control sub-
strate (Fig 2A), and the binding reactions all contain 1 μg calf thymus DNA.
BPs gp33136 is longer than gp33103 because of an additional 33 residues at its C-terminus.
The C-terminal extension includes the ssrA tag that targets the protein for proteolysis, and sta-
bilization of the protein by an A135E substitution gives higher levels of lysogeny. However, we
noted previously that the gp33136 A135E mutant appears to give a modest increase in activity
of the Prep promoter in a reporter fusion assay [13], perhaps providing transcriptional activa-
tion that is dependent on the C-terminal 33 residues. We therefore compared the binding pro-
files of gp33103 and gp33136 for any differences in binding to the 33–34 intergenic region that
contains both Prep and PR (Figs 1 and 2B). Both proteins give similar profiles and the additional
33 C-terminal residues in gp33136 do not appear to substantially influence DNA binding. It is
likely that any functional activation of Prep results from protein-protein interactions, perhaps
reflecting direct contacts between BPs gp33136 and RNA Polymerase.
The 185 bp DNA segment contains only a single copy of the 12 bp sequence 5’-CGACA
TATGTCG that was previously predicted to be recognized by gp33103, and yet the complexes
formed are more varied than would be expected for a single protein-DNA interaction. Presum-
ably, the protein binds to additional sites within this region, binds with varying protein-
DNA stoichiometries, or imposes significant DNA distortions. We note that there is a related
sequence (5’-CGACATACCGGC) at the left end (33-proximal) of the intergenic region that
overlaps the Prep transcription start site (Fig 1B), although the similarity is restricted to the left
half of the sequence motif. We therefore sought to dissect the various determinants of gp33103
binding to this region, and to compare this to the binding of gp33103 to the other sites located
elsewhere in the BPs genome.
Solution multimeric state of BPs gp33103
First, we determined the oligomeric state of gp33103 in solution. A single protein peak was
observed using size-exclusion chromatography, and when compared with protein markers,
has an apparent molecular mass of 40.4 kDa (Fig 2C). The monomeric mass of gp33103 is 11.2
kDa, and the simple interpretation is that the major peak corresponds to a gp33103 tetramer,
although we cannot rule out the possibility that it is an alternative multimer shaped to give
altered elution in the chromatography. We note that the 12 bp operator described previously
[13] has dyad symmetry (Fig 1B) consistent with recognition by either a dimer or tetramer of
gp33103. The gp33103 elution profile did not show any other prevalent forms and the oligomeric
state is quite homogenous.
DNase I footprinting of the 33–34 intergenic region
DNase I footprinting provides further insights into the binding of gp33103 to the 33–34 inter-
genic region (Fig 3A). Depending on the gp33103 concentration, two different patterns of
altered DNase I sensitivity are observed. At intermediate concentrations (5.4 μM– 54 μM) we
see prominent protection from DNase I cutting at positions in and around the 12 bp palin-
dromic sequence although some cut sites remain sensitive to DNase I cleavage (Fig 3A). How-
ever, there are notable enhancements of DNase I cutting to the left of the 12 bp palindrome
situated approximately 20 bp and 30 bp away respectively (Fig 3A, S1 Fig). At the highest con-
centrations of protein used (160 μM), DNase I protection is more extensive within this region
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and extends to two regions (designated regions 3 and 4; Figs 1C and 3A) flanking the DNase I
enhancement located about 20 bp to the left of the 12 bp palindrome. There is also protection
in the gene 33 proximal end of the substrate in regions designated 1 and 2, with apparent
DNase I enhancement between them (Figs 1C and 3A). As the conditions for DNase I foot-
printing and native gel electrophoresis of complexes are somewhat different it is not possible to
draw a direct comparison between the two, although it is likely that the slowest moving of the
Fig 2. Both forms of gp33 bind similarly to the BPs 33–34 intergenic region. (A) EMSA analysis shows
that gp33103 binds to the 33–34 intergenic region with a complicated pattern of binding with four distinct
complexes, labeled C1, C2, C3, and C4. No binding was seen between gp33103 and a non-speciic DNA
substrate. Protein concentrations are as follows: 1) none 2) 0.16 μM 3) 0.54 μM, 4) 1.6 μM, 5) 5.4 μM, 6)
16 μM, 7) 54 μM. (B) DNA binding assays show that both gp33103 and gp33136 bind similarly to a DNA
substrate containing PCR amplified DNA from the BPs gene 33–34 intergenic region (S1 Table). Protein
concentrations are as shown in A. (C) Size-exclusion chromatograms for gp33103 (orange) and the molecular
weight markers (green; 66kDa, 29kDa, 12.4kDa, 6.5kDa) are overlayed. (D) The inset graph shows a
standard plot for the molecular mass for the protein standards against the ration of their elution volume (Ve)
and void volume (Vo) (blue diamonds); the molecular mass of gp33103 is predicted to be 40.4kDa (orange
diamond).
doi:10.1371/journal.pone.0137187.g002
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protein-DNA complexes corresponds to the more extensive DNase I protections seen at the
highest protein concentration, and that the faster migrating complexes correspond to those
seen at intermediate concentrations (Figs 2A and 3A).
Because of these DNase I protection patterns together with the experiments described
below, we propose that the gp33103 binding site at PR spans a larger region than just the 12 bp
palindrome, and that this palindrome is equivalent to a half site, of which region 4 (and per-
haps part of region 3) constitute the other half site, not withstanding the sequence dissimilari-
ties (see Fig 1C). To simplify the presentation and discussion of data below, we will refer to the
12 bp palindrome as OR-R and the region to the left that includes region 4 as OR-L (Fig 1B)
reflecting the right and left half sites of OR respectively. The regions 1 and 2 of protection at
Prep will be referred to as ORep.
Binding of gp33103 to subsites in the 33–34 intergenic region
The binding of gp33103 at ORep seen by DNase I footprinting was somewhat unexpected as this
region lacks a site equivalent to OR or an obvious OR half site (OR-L or OR-R), although it has a
distantly related sequence (Fig 1C). However, occupancy of the ORep site is evident at the high-
est protein concentration in DNase I footprinting (Fig 3) and may depend on concomitant
binding of gp33103 elsewhere in the DNA fragment, such as at OR.
To further explore these interactions we synthesized a series of small (40 bp) dsDNA sub-
strates, containing segments of the 33–34 intergenic region (Fig 1C) and asked whether gp33103
Table 1. Binding affinities of gp33103 to various DNA substrates.
Mutant Name Mutation in 33–34 region Average Kd (Molar)
Wild type 33–34 region None 2.61 x 10−6
102a T29489C 7.05 x 10−6
102e A29486C 7.80 x 10−6
102j 151bp Inversion (29282–29432) 4.23 x 10−6
102k 24bp Duplication (29472–29495) 6.67 x 10−6
127b 151bp Deletion (29323–29473) 9.50 x 10−6
127c 33bp Duplication (29495–29527) 3.50 x 10−6
127d 12bp Duplication (29474–29485) 2.99 x 10−6
127e 6bp Duplication (29483–29488) 3.81 x 10−6
Δ32 Clr1 T29336C 1.74 x 10−6
Δ32 Clr4 G29500A 1.45 x 10−6
33A129E Clr5 C29372T 2.90 x 10−6
33A129E Clr6 T29475C 2.65 x 10−6
Δ32 Clr8 T29501C 2.80 x 10−6
5–6 intergenic region None 2.75 x 10−6
26–27 intergenic region None 9.00 x 10−7
54–55 intergenic region None 2.60 x 10−6
60–61 intergenic region None 3.40 x 10−6
O6-L None 1.05 x 10
−5
O27-R None 1.10 x 10
−5
O27-L None 3.85 x 10
−5
O55-L None 8.50 x 10
−6
O61-R None 1.95 x 10
−5
TIR-5 None 1.25 x 10−5
TIR-6 None 9.50 x 10−6
doi:10.1371/journal.pone.0137187.t001
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binds and forms protein-DNA complexes (Fig 3C). The protein binds to the TIR-6 substrate
(Figs 1C and 3C) containing OR-R to form a single complex, but binds similarly to the TIR-5
substrate to form complexes with similar mobilities (Fig 3C), which was unexpected as the
TIR-5 substrate lacks the 12 bp palindromic sequence previously identified as OR [13]. The
Fig 3. BPs gp33103 binds to several regions within the 33–34 intergenic region. (A) DNase I footprinting assays (panels A and B) were done using 5’
end-labeled probes of the 33–34 intergenic region, which were incubated with increasing concentrations of gp33103, subjected to DNase I cleavage, and run
on a denaturing gel alongside a sequencing ladder. Black arrows show the direction of the sequence from 5’ to 3’ for each DNA strand. Regions of protection
from DNase I cleavage are indicated by black bars and labeled; the sequence of OR is also shown. Protein concentrations are as follows: 1) none 2) 0.16 μM
3) 0.54 μM, 4) 1.6 μM, 5) 5.4 μM, 6) 16 μM, 7) 54 μM, 8) 160 μM. Two regions of protection observed near Prep, one of which contains ORep (Regions 1 and 2).
Three regions of protection are observed near PR (Regions 3 and 4, Region 5), one of which includes OR-R (Region 5). The sequences of the protected
regions are shown in Fig 1C. See also S1 Fig (B) EMSAs showing gp33103 binding to 40 bp substrates spanning the 33–34 intergenic region (see Fig 1C).
Binding occurs to the TIR-6 fragment containing OR-R and to substrate TIR-5, which contains Region 3 and Region 4 (OR-L) and only one base pair of OR-R.
(A). Protein concentrations are as follows: 1) none 2) 0.16 μM 3) 0.54 μM, 4) 1.6 μM, 5) 5.4 μM, 6) 16 μM, 7) 54 μM.
doi:10.1371/journal.pone.0137187.g003
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TIR-5 substrate contains OR-L but does not contain OR-R (see Fig 1C). A plausible explanation
is that gp33103 binds as a dimer or tetramer to OR-L and OR-R independently and at reduced
affinity, notwithstanding the sequence differences. In this model, binding of a tetramer would
involve two unoccupied helix-turn-helix DNA binding domains, which would be available for
binding either to another site within the same substrate (perhaps ORep) with introduction of a
DNA loop, or by forming intramolecular bridges between two different DNAmolecules.
Binding of gp33103 to deletion substrates of the 33–34 intergenic region
To further examine the parts of the 33–34 intergenic region required for binding we generated
a series of substrates containing progressive deletions from each end and tested them for bind-
ing of gp33103 (Fig 4). One notable observation is that the binding patterns with the Mt12 and
Mt13 substrates (Figs 1C and 4) are similar, even though OR-R is present in Mt13 but absent
fromMt12. The affinity for Mt12 is slightly reduced relative to that for Mt13, but we assume
that the slowest migrating complexes (C4) have similar stoichiometries, with each containing a
dimer or tetramer of gp33103 bound at OR in addition to binding elsewhere in the substrate.
One of the Mt13 complexes (C3) appears to be absent from the Mt12 substrate, and presum-
ably requires OR-R (Figs 1 and 4). Complete removal of both OR-L and OR-R (substrates Mt10
and Mt11) does not completely eliminate binding and complexes are observed albeit with
reduced binding affinity (Fig 4; Table 1), reflecting weaker binding to the left part of the
substrate.
Deletion substrates lacking Prep-proximal regions but retaining OR (i.e. Mt6 and Mt7) form
similar complexes, although the major complexes have somewhat different relative mobilities
(0.69, 0.55, and 0.50 for Mt3, Mt4, and Mt5 respectively), perhaps reflecting DNA distortions
(Fig 4). Inclusion of either part (i.e. Mt6) or all (i.e. Mt7) of the putative ORep site imposes little
overall change to the pattern of complex formation (Fig 4), even though DNase I footprinting
(Fig 3A) shows that gp33103 binds at the higher protein concentration to substrate similar to
Mt7; furthermore, gp33103 forms complexes with substrates Mt10 and Mt 11 that lack OR (Fig
4). It is unclear whether gp33103 binds separately at OR and ORep or if one or more tetramers of
gp33103 bind simultaneously at ORep and OR to form a DNA loop.
BPs gp33103 introduces a DNA bend when bound to the 33–34
intergenic region.
To further explore the binding interactions between gp33103 and this 33–34 control region, we
constructed two series of substrates in plasmid pBEND2 [20], one containing only OR-R and
one containing the full 33–34 intergenic region. We then determined the relative mobilities of
complexes formed with gp33103 as a function of the position of the sites relative to the ends of
the DNA molecules; substrates with a protein-induced bend migrate slowest if the bend is in
the center of the substrate (Fig 5). We saw no evidence of DNA bending when only OR-R was
present (Fig 5A), but a clear indication of a protein-induced DNA bend with the larger sub-
strate (Fig 5B). No intrinsic bending of 33–34 intergenic region was observed, but bending was
indicated in at least two of the protein-DNA complexes (Fig 5B). The magnitude of the overall
bend is estimated to be about 40°, although we note that this could arise from multiple protein-
DNA interactions. This is consistent with introduction of a bend when gp33103 is bound as a
tetramer to OR-L and OR-R, but it is difficult to exclude the possibility of a hairpin-like DNA
loop even though the overall bend is less than might be expected. These observations are also
consistent with the interpretation that the relative mobilities of the complexes observed with
other substrates are influenced by DNA distortions (Fig 4).
Mycobacteriophage BPs Repressor
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BPs gp33103 does not promote intermolecular bridges
An alternative explanation for the observed gp33103 complexes is that gp33103 tetramers bind
simultaneously to two different DNAmolecules to promote intermolecular protein-bridges. To
test this, we performed DNA binding assays with two different sized DNA fragments, sepa-
rately and together (Fig 5C). Both DNA fragments give a similar series of complexes, and when
mixed together, we observe only a combination of the complexes formed with the individual
substrates, and no new complexes with mobilities suggesting that they contain more than one
DNA fragment. We conclude that under these conditions although the complexes may have
Fig 4. BPs gp33103 binds with variable affinities to a series of end-deletion substrates. Substrates were
PCR amplified from the BPs 33–34 intergenic region using primers located at regular intervals from each end
to sequentially shorten the 33–34 intergenic region from each end (S1 Table). The sequences included in
each substrate are shown as horizontal black lines either above or below a schematic representation of the
33–34 intergenic region. Genes 33 and 34 are represented by blue and orange arrows respectively, and OR
and ORep are shown in yellow. Protein concentrations are same as shown in Fig 2A. Protein affinities are
shown in Table 1.
doi:10.1371/journal.pone.0137187.g004
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differing numbers of gp33103 protomers, they each contain only a single DNAmolecule. We
cannot exclude the possibility that bridging interactions are observed under other conditions
including high substrate concentration.
Additional gp33103 binding sites in the BPs genome
BPs gp33103 is known to bind to several additional sites within the BPs genome [13] and we
investigated whether there are similar complexities to the binding of gp33103 at these sites.
Three other instances of sequences identical to OR-R are located in small intergenic regions,
Fig 5. BPs gp33103 bends DNA but does not facilitate loop formation. (A) The 12bp of OR was cloned into
plasmid pBend2 [20] using unique restriction enzyme sites SalI and XbaI to create pVMV22. Equal-sized
fragments of DNA were excised from pVMV22 with OR located at different positions relative to the edge of the
probe by cleaving with appropriate enzymes. BPs gp33103 (0.54μM) was incubated with each radiolabeled
probe and run on a native polyacrylamide gel. The only gp33103-DNA complex (C1) does not show any
differences in relative mobility with different substrates. (B) A second plasmid containing the entire BPs 33–34
intergenic region (pVMV21) was analyzed similarly, suggesting that a bend of about 40° is introduced into the
major complex (equivalent to C-4, Fig 2A) by gp33103 binding. (C) To determine if intermolecular DNA bridges
are formed by gp33103, two different sized fragments of DNA containing the 33–34 intergenic region (366 bp
and 256 bp) were PCR amplified and radiolabeled (S1 Table). The leftmost six lanes contain only the 366 bp
substrate, the middle six lanes contain only the 256 bp substrate, and the rightmost six lanes contain both
substrates. Complexes formed with each substrate are indicated by long and short arrows respectively. The
concentration of protein in each series of substrates is 1) none, 2) 0.54μM, 3) 1.6μM, 4) 5.4μM, 5) 16μM, 6)
54 μM. Protein affinities are shown in Table 1.
doi:10.1371/journal.pone.0137187.g005
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between genes 5 and 6, between genes 26 and 27, and between genes 54 and 55 (Fig 6A and
6B). A site with two base pair differences is located within the 60–61 intergenic region (Fig 6).
In view of the proposition that the 12 bp palindrome at OR-R corresponds to a half-site for
gp33103 binding, we examined the sequences for additional sites related to OR-R. Interestingly,
in all four regions we identified, different but related sequences are positioned either 5 bp (O6,
O27, O61), or 8 bp (O55) away from the other half site, consistent with the 12 bp palindrome
constituting just one of two half sites. We therefore refer to the left and right halves of each of
these as O6-L and O6-R, O27-L and O27-R, O55-L and O55-R, and O61-L and O61-R for O6, O27, O55
and O61 respectively (see Fig 6B).
To test whether these regions play a role in the phage transcriptional program and are sub-
ject to repressor control, each was inserted upstream of amcherry reporter gene and trans-
formed intoM. smegmatismc2155. The 5–6, 26–27, 54–55, and 60–61 regions all have
promoter activity (designated as promoters P6, P27, P55, and P61), although the strengths vary
considerably, with P55 being by far the most active, and P27 the weakest (Fig 6C). Putative pro-
moter elements containing -10 and -35 hexameric motifs are predicted for P6, P55, and P61,
but not confidently for the weaker P27 (Fig 6B). The promoter-reporter plasmids were also
transformed into a BPs lysogen and the promoter activities determined (Fig 6C). The P6, P27,
and P55 promoters are clearly down regulated in a lysogen, presumably by gp33
103 [few other
phage-encoded proteins are expressed in a lysogen as indicated by RNAseq (LMO and GFH,
unpublished observations)] as for the PR control [Fig 6C, [13]]. No regulation for either Prep
or P61 was observed (Fig 6C).
Using native gel electrophoresis, gp33103 was shown to bind to all four substrates (O6, O27,
O55 and O61) to generate a single prominent complex and a minor complex with intermediate
mobility, with the exception of O6 and O55 for which additional complexes were observed (Fig
7D, 7G, 7J and 7M). Presumably, the relative simplicity of the binding patterns compared with
the 33–34 DNA is because of the lack of additional sites equivalent to ORep. The overall affini-
ties are similar to gp33103 binding to the 33–34 intergenic region (Fig 7A, Table 1), although
binding is about 3-4-fold tighter to O27. To dissect out the contribution of the separate poten-
tial half sites, substrates were generated in which one half site was specifically ablated so as to
leave just the 12 bp palindrome (O6-L, O27-R, O55-L, and for O61, O61-R, S1 Table), and tested for
gp33103 binding (Fig 7E, 7H, 7K and 7N). BPs gp33103 binds to each of these to form a single
complex, but with substantially reduced affinity (Table 1). We then inserted the other half sites
(O6-R, O27-L, O55-R, O61-L) individually into a common sequence context (S1 Table) and tested
gp33103 binding (Fig 7F, 7I, 7L and 7O). All of these were bound only very weakly, although
complexes were detected with the O27-L substrate (Figs 6B and 7I). These binding data suggest
that gp33103 binds to DNA containing two half sites, presumably as a tetramer, and the reduced
mobility of the complexes formed by gp33103 and each full site is slower than for complexes
with individual half sites. Although we cannot rule out the possibility that these complexes
have different protein-DNA stoichiometries, it is plausible that these differences reflect a pro-
tein-induced bend when the full site is bound, as seen at OR.
Binding of gp33103 to adjacent 12 bp palindromes
To further test the binding of gp33103 to two half sites, we generated a series of 42 bp substrates
each containing two 12 bp palindromic sequences spaced either 5 bp or 8 bp apart (Fig 8). We
also made derivatives of these in which either the left or right half site was mutationally ablated,
and examined gp33103 binding. With a 5 bp inter-site spacing, BPs gp33103 binds to form a
single complex which has a slower mobility than those formed when each of the half sites is
ablated (Fig 8B). Although the affinities for the three substrates are similar, there is suggestion
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of cooperative binding to two adjacent sites, as no complex corresponding to single site occu-
pancy is present. A plausible explanation is that the binding energy gained from cooperative
binding is balanced by an investment of binding energy into either DNA bending or conforma-
tional distortion of the protein. When two 12 bp palindromes are separated by 8 bp (Fig 8A),
both the faster and the slower migrating complexes are formed, suggesting lack of cooperative
Fig 6. Complete and partial operator sites found throughout the BPs genome. (A) Map of the BPs
genome showing open reading frames (colored boxes) with the positions of each of the operator sites
indicated. (B) Sequences of the intergenic regions containing operators. Promoter sequences (green text),
start codons of open reading frames (blue text), and the stop codons of open reading frames (red text) are
shown. Operator half sites corresponding to the 12 bp sequence 5’-CGACATATGTCG are highlighted in
yellow. Operator half sites containing sequence departures within these 12 bp sites are highlighted in orange
or pink (reflecting gp33103 binding or no observed binding respectively; see Fig 7). ORep-R and OR-L are
highlighted in gray. Confirmed transcription start sites are marked as +1 [[13] L. Oldfield and GFH, manuscript
in preparation]. (D) Promoter fusions to a mCherry reporter gene were constructed in an integration-proficient
vector, transformed into bothM. smegmatis (blue bars) and a BPs lysogen (red bars) and fluorescence levels
measured.
doi:10.1371/journal.pone.0137187.g006
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Fig 7. BPs gp33103 binding to full and partial operator sites. Binding of gp33103 to each of the intergenic
regions where full and partial sites are found (see Fig 6; Table 1, S1 Table) are shown in gels A, D, G, J, and
M. To examine binding to the O6-L, O27-R, O55-L, and O61-R sites independent from their potential partner sites,
52bp synthetic oligonucleotide substrates were generated with these sites centrally located (S1 Table), and
the partner partial sites (O6-R, O27-L, O55-R, O61-L) were mutationally ablated to have no sequence similarity to
Mycobacteriophage BPs Repressor
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interactions, although the overall affinities are similar to the 5bp spaced substrate suggesting
that DNA bending may also be different.
BPs gp33103 binding to mutant DNAs conferring a repressor-insensitive
phenotype
We previously described the isolation of BPs mutants that are capable of infecting a repressor-
expressing strain, and behave as though they are repressor-insensitive. Two such mutants
(102a and 102e, Fig 9A) were shown to have point mutations in OR-R that reduce the affinity of
gp33103 by about 3-10-fold (depending on specific DNA substrate used), apparently sufficient
for the commitment to lytic growth to outcompete the resident repressor [13]. Three additional
mutants (Clr4, Clr6 and Clr8, Fig 9) contain single substitutions in the regions immediately
flanking OR (Fig 9A; S1 Table). Two of these (Clr4, Clr8) are to the right of OR-R in the pro-
moter -10 region such as to influence PR promoter activity, and to give elevated gp34 synthesis
which is predicted to promote commitment to lytic growth [13]. One mutant (Clr6) is in the
-35 region of PR but is not predicted to influence promoter activity [19]. However, the muta-
tion lies within the putative OR-L site and could therefore influence gp33
103 binding. We exam-
ined gp33103 binding to these three mutants (Fig 8) and observed that all three form complexes
with similar overall affinity as to the wild-type substrate. One interpretation is that repression
of transcription requires a specific tertiary structure, and that point mutations within the bind-
ing site influence this structure, although binding affinity may be little different.
We tested the binding of gp33103 to other mutants with repressor-insensitive phenotypes,
including other point mutations as well as insertions, deletions, and inversions (Fig 9B). Two
mutants (Clr1 and Clr5) have mutations distal to OR and we observe that both form complexes
the 12bp palindrome (gels E, H, K and N). Each of the partially conserved partner sites (O6-R, O27-L, O55-R,
O61-L) were placed in a non-native sequence context (42bp substrates; S1 Table) to test for gp33
103 binding
(F, I, L, and O). Binding profiles of gp33103 to OR-R and ORep-L are shown for comparison (B and C). The
concentrations of protein are as follows: 1) none, 2) 0.16μM, 3) 0.54μM, 4) 1.6μM, 5) 5.4μM, 6) 16μM, 7)
54 μM. Protein affinities are shown in Table 1.
doi:10.1371/journal.pone.0137187.g007
Fig 8. BPs gp33103 binds to two adjacent 12 bp palindromes. (A and B) EMSAs showing gp33103 binding to substrates containing two 12bp palindromic
half sites (yellow boxes) spaced either 8 bp (panel A) or 5 bp apart (panel B). Substrates in which one half site is mutationally ablated is shown as a white box.
doi:10.1371/journal.pone.0137187.g008
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Fig 9. BPs gp33103 binding to substrate variants of the 33–34 intergenic region derived from repressor-insensitive BPsmutants. (A) Locations of the
mutations in each substrate (see Table 1). (B) Binding profiles of gp33103 to each 33–34 substrate. The concentrations of protein are as follows: 1) none, 2)
0.16μM, 3) 0.54μM, 4) 1.6μM, 5) 5.4μM, 6) 16μM, 7) 54μM. Protein affinities are shown in Table 1.
doi:10.1371/journal.pone.0137187.g009
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with similar relative mobility and affinity as the parent substrate, and the basis for their pheno-
types is not clear (Fig 9, Table 1).
Six other repressor-insensitive mutants have more substantial DNA rearrangements in the
33–34 region (Fig 9A; Table 1). Four of these (102k, 127c, 127d, 127e) have small duplications
near the PR/OR region, and gp33
103 binds to all of them with similar affinity to the wild-type
substrate (Fig 9B). However, the profiles of the complexes differ to that of the wild-type, consis-
tent again with the hypothesis that formation of a protein-DNA complex with a specific config-
uration is important for regulation. A mutant (127b) containing a large deletion and missing
much of the intergenic region including ORep and OR-L but retaining OR-R forms complexes
with much faster relative mobility that those seen with other substrates, indicating that perhaps
either a monomer or dimer of gp33103 is binding, although the basis for such an unusual prop-
erty is unclear.
Discussion
We have described here the unusual binding properties of the repressor encoded by mycobac-
teriophage BPs. The repressor is non-canonical in that it is encoded in two forms, a virally-
encoded product 136-residues long (gp33136), and prophage-encoded version (gp33103) that is
33 residues shorter as a consequence of integrative recombination at the attP site situated
within the gene 33 open reading frame. The two proteins bind similarly to a DNA substrate
containing the regulatory region between genes 33 and 34, but the binding pattern is complex
with multiple protein-DNA complexes observed (Fig 2). The binding affinity is surprisingly
weak relative to other phage repressors, although the gp33103 and gp33136 binding affinities are
similar to each other, and other preparations have similar affinities. The gp33 preparations
retain five non-native residues at the N-terminus that we have not been able to remove without
encountering insolubility, and these could influence the binding affinity. However, we also
note that BPs lysogens have high levels of spontaneous lytic induction, which could reflect rela-
tively weak binding of the repressor in vivo.
BPs gp33103 binds to a total of five loci within the BPs genome and three promoters (P6, P27,
and P55) in addition to PR. Alignment of the six putative DNA binding sites (O6, O27, ORep, OR,
O55, and O61) shows the juxtaposition of the half sites within each operator (Fig 10A). In three
of the sites (O6, O27, and O55), one half site contains the 12 bp palindrome (O6-L, O27-R, and
O55-L) and is easily recognizable, and the other half sites (O6-R, O27-L, and O55-R) contain
sequence departures at two or three positions (Fig 10A). At O61, both half sites have sequence
departures from the consensus (two in O61-R and and four in O61-L) although gp33
103 binds
with similar affinity as it does to O6 and O55 (Fig 7). OR is peculiar in that it contains the easily
recognizable OR-R, but the other half site is only distantly related, although gp33
103 clearly binds
to it, even in the absence of OR-R (Fig 3). We propose the sequence 5’-GCGCATTTTCCA for
OR-L which has only five bases of the 12 bp palindrome (Fig 10A). However, this is spaced five
bases away fromOR-R, which is similar to the geometries of O6, O27, and O61 and which appears
to permit cooperative binding (Fig 8). We also note that position eight of this proposed OR-L is
part of the PR -35 motif, and substitution with a G base both increases promoter activity, but
also reduces the efficiency of repression [19], consistent with the role of OR-L in binding and reg-
ulation. The sequences of the ORep half sites are the most divergent, and the best alignment sug-
gests that ORep-L and ORep-R have eight and seven positions conserved respectively, spaced eight
bases apart with a geometry similar to that of O55. DNase I footprinting is consistent with bind-
ing to these sites, and complexes are observed with the small substrate tested that contains the
complete sequence (Mt10, Fig 4). At least at higher protein concentrations, binding of gp33103
to the 33–34 intergenic regions is expected to involve occupancy of both OR and ORep. Although
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we cannot exclude the possibility that gp33103 forms a DNA loop by simultaneous occupancy of
OR and ORep, the 113 bp OR-ORep intersite spacing is substantially below the persistence length
of DNA, and DNA looping would likely require either phased A/T tracts to promote DNA
bending or an accessory DNA bending protein such as HU.
Fig 10. Site alignments andmodels of BPs gp33103 binding. (A) Alignment of all operators found in the BPs genome. Bases in black correspond to the
consensus 12bp half site sequences. Bases in gray indicate positions that are present at that position in four or more sites. No shading indicates bases that
are present in three or fewer sites. The consensus sequence is shown below the alignment. (B-I) Various plausible configurations of gp33103 binding to OR
(and related sites) are shown. See text for details.
doi:10.1371/journal.pone.0137187.g010
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The nature of the specific protein-DNA interactions suggests there are several plausible
models to consider (Fig 10). The previously identified 12 bp palindromic sequence 5’-CGA
CATATGTCG is typically associated with a related sequence spaced 5–8 bp away, and surpris-
ingly even though the OR-L site is a highly redundant version with only five of the 12 positions
conserved (Fig 10A), there is good evidence that gp33103 binds to it, even when OR-R is
removed (Fig 3C). One set of models includes binding of two protomers to each of the 12 bp
sequences within an overall site (e.g. OR or O27) (Fig 10B–10E) with the stoichiometry reflect-
ing either a dimer bound to each 12 bp half-site (Fig 10B and 10C), or a tetramer bound to
each 12 bp half site (Fig 10D and 10E). The DNA could be relatively straight (Fig 10B and
10D), or could include a modest DNA distortion (Fig 10C and 10E), although we favor the
bent DNA models (Fig 10C and 10E) both because of the observed bends seen in Fig 5 and the
DNase I enhancement observed at the centers of both OR-L and OR-R (Fig 3A). A second set of
models proposes that a single protomer recognizes each 12 bp motif (Fig 10F–10I), with corre-
sponding stoichiometries and bending considerations (Fig 10F–10I) as described for the two-
protomer models (Fig 10B–10E). Although 12bp is a somewhat larger segment of DNA than
usually recognized by a helix-turn-helix DNA binding motif, it is not unprecedented, and we
note that a protomer of γδ resolvase recognizes a similarly-sized half site with contacts span-
ning both major and a minor grooves of the DNA [21, 22]. The palindromic nature of many of
the 12 bp half sites supports two-protomer/half-site models, although we note that the symme-
try with the 12 bp sequences is not conserved in all sites.
There is evidence of cooperativity in the occupancy of two 12 bp half sites, but spacing
between the sites plays an important role. Cooperative binding appears to be supported by a 5
bp inter-site spacing (Fig 8) as in OR, but could occur between single protomers, dimers, or tet-
ramers bound at each half site (Fig 10). However, investment of binding energy into DNA
bending and the DNase I hypersensitivity seen within OR and ORep supports models that
include an inter-site bend (Fig 10C, 10E, 10G, and 10I). We note that although models in
which a protein dimer (as in Fig 10G) binds to two differently spaced half sites (e.g. 5 and 8 bp)
is somewhat unusual, it is observed in the binding of γδ resolvase, where the two half sites
within each of three binding sites are separated by 4, 10, and 1 bp respectively [22].
Despite the complexity of the binding profile of gp33103 to the 33–34 intergenic region,
formation of properly configured complexes is necessary for normal repression in a lysogen.
BPs mutants with repressor-insensitive phenotypes that have mutations mapping to the 33–
34 intergenic region demonstrate the importance of this sequence and the ability of gp33103
to bind to it (Fig 9). Loss of normal repression does not closely correlate with large changes
in binding affinity, and it is likely that relatively subtle sequence changes give rise to altered
configurations that interfere with repression. This notwithstanding, some DNA substrates
of the repressor-insensitive mutants have binding patterns that are more consistent with
binding of monomers or dimers (e.g. 127b, Fig 9B), and it is unclear what determines this
behavior.
The system of integration-dependent immunity seen in BPs and other phages offers a quite
different perspective on phage life style decision making than seen in phage lambda and its rel-
atives, and may represent an ancestral state for temperate phages [12]. It is perhaps not surpris-
ing that the repressor has non-canonical binding properties including tetramerization and
binding to dispersed sites in the phage genome (Fig 10). Because the repressor can be expressed
in two forms that differ in their C-termini, this raises the possibility that the virally-encoded
product gp33136 forms mixed tetramers with the shorter protein (gp33103) and influences func-
tionality even if not binding per se. Thus the observed tetramerization and DNA binding pro-
files may play roles in modulating the overall genetic switch in these phages.
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Materials and Methods
Expression and Purification of gp33103 and gp33136
The gp33103 and gp33136 genes were PCR amplified from a BPs lysate using primers 5’-CAA
TCG CCC ATA TGT CGC AAG CAT TCG -3’ / 5’- GAC TAC AAG CTT TCA GAA GGT TGG
GGG TTC GA 3’and 5’-CAA TCG CCC ATA TGT CGC AAG CAT TCG -3’/ 5’- TGC CGG
AAG AAG CTT TCA CGA CGC TTT ATC C -3’ respectively, which amplified the genes with
NdeI recognition sites at the 5’ end of the gene and HindIII recognition sites at the 3’ end. Each
gene was cloned into a maltose-binding fusion vector (pLC3) that was linearized with NdeI
and HindIII sites for directional cloning, creating two plasmids pVMV20 and pVMV27 for
gp33103 and gp33136 respectively. pVMV20 and pVMV27 were transformed into BL21(DE3)
star chemically competent cells (Invitrogen) and grown until cultures reached an OD600 of 0.4–
0.6. Protein expression was induced with 1 mM IPTG at 17°C overnight. Cells were pelleted
and frozen at -80°C. Thawed cell pellets were resuspended in 5mL per gram of Lysis Buffer (50
mM Tris pH 8.0, 500 mMNaCl, 8% glycerol, 1 mM EDTA and 1 mM β-mercaptoethanol) and
lysed in 200 mL fractions by sonicating 10 times for 10 sec at 30% output with 30 sec of cooling
on ice in between bursts. Pooled cell lysates were cleared by centrifugation at 30,000 x g for 40
min at 4°C. Fusion proteins were extracted from soluble cell lysates using amylose resin affinity
chromatography (Invitrogen) and the MBP tag was cleaved from the proteins of interest with
TEV protease during overnight dialysis at 4°C. MBP and TEV protease contain C-terminal His
tags and were removed from the gp33 proteins using nickel affinity chromatography. The flow
through containing pure gp33 proteins was dialyzed into a storage buffer (50 mM Tris pH 8.0,
500 mMNaCl, 50% glycerol, 1 mM EDTA, 1 mM BME) and stored at -20°C.
DNA Binding Assays
DNA binding assays were carried out according to standard protocols [23]. Briefly, DNA sub-
strates (either PCR substrates or annealed complimentary synthetic oligonucleotides; S1 Table)
were 5’ radiolabeled using ATP, [γ-32P] with T4 polynucleotide kinase (Roche). Binding reac-
tions contained 5–20 cps radiolabeled DNA probe, 1 μg non-specific calf thymus DNA, and
varying concentrations of protein in a binding buffer containing 20 mM Tris pH 7.5, 10 mM
EDTA, 25 mMNaCl, 10 mM spermidine, and 1 mMDTT for a total volume of 10 μl. Reactions
were incubated at room temperature for 30 min and the resulting protein DNA complexes
were resolved on a 5% native gel and detected using autoradiography and a phosphorimaging
plate.
DNase I Footprinting
Footprinting assays were carried out as previously described [23]. Briefly, binding reactions
were carried out in a final volume of 50 μl containing various concentrations of protein, 20cps
radio labeled probe, 25 mM Tris-HCL pH 8.0, 50 mM KCl, 6.25 mMMgCl2, 0.5 mM EDTA,
10% Glycerol, 0.5 mMDTT. Binding reactions were incubated at room temperatures for 30min.
After incubation, 50 μl of a solution containing 5 mM CaCl2 and 10 mMMgCl2 was added to
the samples and incubated for 1 minute. Samples were treated with 1.5U DNaseI for exactly one
minute, then the digestion reaction was stopped by addition of 90μl of a pre-warmed (37°C)
Stop solution (200 mMNaCl, 30 mM EDTA, 1% SDS, 100 μg/mL yeast RNA). Samples were
PCI (Invitrogen) extracted and ethanol precipitated. Samples were resuspended in 2–3 μl form-
amide loading buffer and heated to 95°C for 2 minutes before loading onto a 6% polyacrylamide
7 M urea denaturing gel for resolution. Bands were detected using autoradiography or exposed
on a phosphorimageing plate and detected on a FLA-5100; FujiFilm imaging system.
Mycobacteriophage BPs Repressor
PLOS ONE | DOI:10.1371/journal.pone.0137187 September 2, 2015 19 / 21
Size Exclusion Chromatography
Purified gp33103 was dialyzed into a buffer containing 10 mM Tris, pH 8.0, 1 mM BME, 500
mMNaCl, and 4.5% glycerol. 1.2 mL of protein was run over a G-120 column using FPLC, 0.5
ml elution fractions were collected and peaks was identified with UV 280 absorbance measure-
ments. Gel filtration molecular weight markers (Sigma-Aldrich) were resuspended in the same
buffer at manufacturer recommended concentrations and run over the same column. The
molecular mass for the gel filtration standards were plotted against elution volume (Ve) over
void volume (Vo) to determine the molecular mass of gp33103 based on its elution volume.
Fluorescent Reporter Assays for Promoter Strength
The vectors were constructed by creating transcriptional fusions of regions of the BPs genome
with predicted promoter elements to a codon-optimized mCherry fluorescence gene. The pro-
moter-mCherry vectors were transformed into electrocompetentM. smegmatismc2155 and a
BPs lysogen ofM. smegmatismc2155, as previously described [24]. Fluorescence assays were
performed as previously described [19]. Briefly, transformants were grown in biological tripli-
cates under selection shaking at 37°C for 48 hours. From these cultures, 50 μl was aliquoted
into 96-well plates (Falcon). Fluorescence was detected at 532 nm (FLA-5100; FujiFilm) and
normalized to the optical density at 595 nm (EL800 Universal Microplate Reader; Bio-Tek
Instruments) of the aliquot to account for cell density. Fluorescence units were reported as
(LAU)/mm2)/OD595nm. Graphs display the mean fluorescence units ± 95% confidence interval.
Supporting Information
S1 Fig. DNase I footprinting of the 33–34 intergenic region. DNase I footprint used the
same substrate and conditions as shown in Fig 3A, except that this is a separate experiment
with a clearer DNA ladder.
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S1 Table. Sequence of DNA substrates used in EMSAs.
(DOCX)
Acknowledgments
We thank Andrea Berman and colleagues for help with size exclusion chromatography and
Andrew VanDemark and colleagues with assistance in purification of gp33103 and gp33136, as
well as their kind gift of the pBEND2 vector. We also thank Travis Mavrich for comments on
the manuscript.
Author Contributions
Conceived and designed the experiments: VMV LMO GFH. Performed the experiments: VMV
LMO. Analyzed the data: VMV LMO GFH. Contributed reagents/materials/analysis tools:
VMV LMO. Wrote the paper: VMV LMO GFH.
References
1. Ptashne M. A Genetic Switch. Oxford/Cambridge: Blackwel Science Ltd and Cell Press; 1987.
2. Little JW. Evolution of complex gene regulatory circuits by addition of refinements. Curr Biol. 2010; 20
(17):R724–34. Epub 2010/09/14. S0960-9822(10)00773-6 [pii] doi: 10.1016/j.cub.2010.06.028 PMID:
20833317.
3. Ptashne M, Johnson AD, Pabo CO. A genetic switch in a bacterial virus. Sci Am. 1982; 247(5):128–30,
32, 34–40. PMID: 6216590
Mycobacteriophage BPs Repressor
PLOS ONE | DOI:10.1371/journal.pone.0137187 September 2, 2015 20 / 21
4. Lewis D, Le P, Zurla C, Finzi L, Adhya S. Multilevel autoregulation of lambda repressor protein CI by
DNA looping in vitro. Proc Natl Acad Sci U S A. 2011; 108(36):14807–12. Epub 2011/08/30.
1111221108 [pii] doi: 10.1073/pnas.1111221108 PMID: 21873207; PubMed Central PMCID:
PMC3169136.
5. Hatfull GF, Hendrix RW. Bacteriophages and their Genomes. Current Opinions in Virology. 2011; 1,
298–303.
6. Smith MC, Burns RN, Wilson SE, Gregory MA. The complete genome sequence of the Streptomyces
temperate phage phiC31: evolutionary relationships to other viruses. Nucleic Acids Res. 1999; 27
(10):2145–55. PMID: 10219087
7. Sinclair RB, Bibb MJ. The repressor gene (c) of the Streptomyces temperate phage phi c31: nucleotide
sequence, analysis and functional cloning. Mol Gen Genet. 1988; 213(2–3):269–77. PMID: 3185504.
8. Hatfull GF, Sarkis GJ. DNA sequence, structure and gene expression of mycobacteriophage L5: a
phage system for mycobacterial genetics. Mol Microbiol. 1993; 7(3):395–405. Epub 1993/02/01. PMID:
8459766.
9. Donnelly-Wu MK, JacobsWR Jr, Hatfull GF. Superinfection immunity of mycobacteriophage L5: appli-
cations for genetic transformation of mycobacteria. Mol Microbiol. 1993; 7(3):407–17. PMID: 8459767.
10. Smith MC, Owen CE. Three in-frame N-terminally different proteins are produced from the repressor
locus of the Streptomyces bacteriophage phi C31. Mol Microbiol. 1991; 5(11):2833–44. PMID:
1779769.
11. Brown KL, Sarkis GJ, Wadsworth C, Hatfull GF. Transcriptional silencing by the mycobacteriophage L5
repressor. Embo J. 1997; 16(19):5914–21. Epub 1997/10/06. doi: 10.1093/emboj/16.19.5914 PMID:
9312049; PubMed Central PMCID: PMC1170222.
12. Broussard GW, Hatfull GF. Evolution of genetic switch complexity. Bacteriophage. 2013; 3(1):e24186.
doi: 10.4161/bact.24186 PMID: 23819104; PubMed Central PMCID: PMC3694055.
13. Broussard GW, Oldfield LM, Villanueva VM, Lunt BL, Shine EE, Hatfull GF. Integration-dependent bac-
teriophage immunity provides insights into the evolution of genetic switches. Mol Cell. 2013; 49(2):237–
48. doi: 10.1016/j.molcel.2012.11.012 PMID: 23246436; PubMed Central PMCID: PMC3557535.
14. Hatfull GF. The secret lives of mycobacteriophages. Adv Virus Res. 2012; 82:179–288. doi: 10.1016/
B978-0-12-394621-8.00015-7 PMID: 22420855.
15. PopeWH, Bowman CA, Russell DA, Jacobs-Sera D, Asai DJ, SEA-PHAGES, et al. Whole genome
comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diver-
sity. eLIFE. 2015;In press.
16. PopeWH, Jacobs-Sera D, Russell DA, Peebles CL, Al-Atrache Z, Alcoser TA, et al. Expanding the
Diversity of Mycobacteriophages: Insights into Genome Architecture and Evolution. PLoS ONE. 2011;
6(1):e16329. doi: 10.1371/journal.pone.0016329 PMID: 21298013
17. Petrova ZO, Broussard GW, Hatfull GF. Mycobacteriophage-repressor mediated immunity as select-
able genetic markers: Adephagia and BPs repressor-selection. Manuscript submitted. 2015.
18. Dedrick RM, Marinelli LJ, Newton GL, Pogliano K, Pogliano J, Hatfull GF. Functional requirements for
bacteriophage growth: gene essentiality and expression in mycobacteriophage Giles. Mol Microbiol.
2013; 88(3):577–89. doi: 10.1111/mmi.12210 PMID: 23560716; PubMed Central PMCID:
PMC3641587.
19. Oldfield LM, Hatfull GF. Mutational Analysis of the Mycobacteriophage BPs Promoter PR Reveals Con-
text-Dependent Sequences for Mycobacterial Gene Expression. J Bacteriol. 2014; 196(20):3589–97.
doi: 10.1128/JB.01801-14 PMID: 25092027.
20. Zwieb C, Adhya S. Plasmid vectors for the analysis of protein-induced DNA bending. Methods Mol Biol.
2009; 543:547–62. Epub 2009/04/21. doi: 10.1007/978-1-60327-015-1_32 PMID: 19378186.
21. Rimphanitchayakit V, Grindley ND. Saturation mutagenesis of the DNA site bound by the small car-
boxy-terminal domain of gamma delta resolvase. Embo J. 1990; 9(3):719–25. PMID: 2155779.
22. Grindley ND, Whiteson KL, Rice PA. Mechanisms of site-specific recombination. Annu Rev Biochem.
2006; 75:567–605. PMID: 16756503.
23. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Current Protocols in
Molecular Biology. New York: Wiley Intersciences; 1996.
24. Bibb LA, Hatfull GF. Integration and excision of the Mycobacterium tuberculosis prophage-like element,
phiRv1. Mol Microbiol. 2002; 45(6):1515–26. PMID: 12354222.
Mycobacteriophage BPs Repressor
PLOS ONE | DOI:10.1371/journal.pone.0137187 September 2, 2015 21 / 21
